| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | CA2419388A1 Substituted dipeptides as growth hormone secretagogues |
| 04/24/2002 | EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/24/2002 | CN1346365A Macrocylic peptides active against the hepatitis C virus |
| 04/24/2002 | CN1346355A Novel inhibitors of farnesyl-protein transferase |
| 04/24/2002 | CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof |
| 04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
| 04/23/2002 | US6376509 Melanocortin receptor agonists |
| 04/23/2002 | US6376484 For prevention and/or treatment of various kinds of inflammatory disease |
| 04/23/2002 | CA2004127C Novel aminobenzoates |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002030958A2 Casein peptide fragments with growth-influencing activity on cell cultures |
| 04/18/2002 | WO2002030957A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells |
| 04/18/2002 | WO2002030956A1 N-alkylglycine trimeres capable of blocking the response to chemical substances, heat stimuli or mediators of neuronal receptor inflammation and compositions containing said trimeres |
| 04/18/2002 | WO2002030955A2 Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use |
| 04/18/2002 | WO2002030922A2 Dioxolane analogs for improved inter-cellular delivery |
| 04/18/2002 | WO2001053330A3 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them |
| 04/18/2002 | WO2001032684A3 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww |
| 04/18/2002 | US20020045583 Use as hypolipidemic |
| 04/18/2002 | US20020045575 Treating inflammatory, autoimmune diseases, including graft-versus-host disease and enhancement of graft/tissue survival following transplant |
| 04/18/2002 | US20020045192 Detection of perferential complex formation in sample; incubate ligand with cell cycle regulatory protein, detect complex formation in sample |
| 04/18/2002 | DE10046934A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren A process for the fermentative production of non-proteinogenic L-amino acids |
| 04/18/2002 | CA2425610A1 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | CA2425520A1 N-alkylglycine trimeres capable of blocking the response to chemical substances, heat stimuli or mediators of neuronal receptor inflammation and compositions containing said trimeres |
| 04/18/2002 | CA2425359A1 Dioxolane analogs for improved inter-cellular delivery |
| 04/17/2002 | EP1196609A2 Catalytically active recombinant memapsin and methods of use thereof |
| 04/17/2002 | EP1196436A2 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 04/17/2002 | EP1196431A1 A substantially crystalline form of melagatran |
| 04/17/2002 | EP1196414A1 Prodrugs of carbamate inhibitors of impdh |
| 04/17/2002 | EP1196401A1 Method for producing 2-aminomethyl-4-cyano-thiazol |
| 04/17/2002 | CN1345332A C-terminal modified (N-substituted)-2 indolylcarbonyldiptides as inhibitors of ICE/CED-3 family of cysteine proteases |
| 04/17/2002 | CN1344801A Method for production of non-proteinogen L-amino acid by fermentation |
| 04/17/2002 | CN1344720A Synthesis of cynnematin |
| 04/17/2002 | CN1082956C Micacocidin derivatives |
| 04/16/2002 | US6372778 Sulfonamide inhibitors of aspartyl protease |
| 04/16/2002 | US6372744 β-sheet mimetics and methods relating to the use thereof |
| 04/16/2002 | US6372717 Acylated tyrosine-arginine dipeptide; applying skin lotion topically; sensitivity; analgesics, wound healing agents |
| 04/16/2002 | US6372712 Complex of peptidyl-propyl cis/trans isomerase and drug such as rapamycin, cyclosporin a, fk-506, or other antibiotic |
| 04/16/2002 | US6372279 Sweetener composition |
| 04/16/2002 | US6372278 N-(n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl)-l-phenyalanine-1 -methyl ester and aspartame; for beverages |
| 04/16/2002 | CA2088980C Pro-drugs for cck antagonists |
| 04/11/2002 | WO2002028885A1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres |
| 04/11/2002 | WO2002028883A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 04/11/2002 | WO2002028882A1 Bile acid prodrugs of l-dopa and their use in the sustained treatment of parkinsonism |
| 04/11/2002 | WO2002028881A1 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
| 04/11/2002 | WO2002028809A2 Dynamic resolution of isomers and resolved isomers |
| 04/11/2002 | WO2002028411A1 Compounds for sustained release of orally delivered drugs |
| 04/11/2002 | WO2002009649A3 Cell internalized peptide-drug conjugates |
| 04/11/2002 | WO2001066147A3 Antimicrobial compounds and formulations |
| 04/11/2002 | WO2000052048A9 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | US20020042396 Amino acid derivatives |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020042102 Synthesis without the use of the cells and their use in vivo as powerful anti-inflammatory, antithrombotic or anti-metastatic compounds |
| 04/11/2002 | US20020042084 Enzymatic reaction of a substrate radiolabelled at the C-terminal glutamate group detected by its binding to fluomicrospheres |
| 04/11/2002 | US20020041878 Monitoring angiogenesis factor |
| 04/11/2002 | DE10048417A1 Verbindungen mit verzweigtem Linker Compounds with branched linker |
| 04/11/2002 | CA2424280A1 Dynamic resolution of isomers and resolved isomers |
| 04/10/2002 | EP1194449A2 Inhibitors of memapsin 2 and use thereof |
| 04/10/2002 | EP1194443A1 Cysteinyl protease inhibitors |
| 04/10/2002 | EP1194164A1 Prion protein peptides and uses thereof |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | EP0946516B1 New histidine derivatives, preparation process, and their use as free antiradical agents |
| 04/10/2002 | EP0863916B1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/10/2002 | CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/09/2002 | US6369106 Treatment of ischemic brain injuries with brain targeted anti oxidant compounds |
| 04/09/2002 | US6369077 Protease inhibitors |
| 04/09/2002 | US6369063 Selective factor Xa inhibitors |
| 04/09/2002 | US6369034 For therapy of cancer, restenosis, and atherosclerosis |
| 04/09/2002 | US6368788 Method of treating complications in immunodepressed states resulting from HIV infection |
| 04/09/2002 | CA2233698C Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/09/2002 | CA2093219C Amides of antibiotic ge 2270 factors |
| 04/04/2002 | WO2002027315A2 Compounds with a branched linker |
| 04/04/2002 | WO2002026775A2 Compositions and methods for regulating apoptosis |
| 04/04/2002 | WO2002026774A2 Melanocortin receptor ligands |
| 04/04/2002 | WO2001072829A3 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 04/04/2002 | US20020040144 For therapy of thrombotic disease, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury |
| 04/04/2002 | US20020039767 Batch processing using nucleophilic compound |
| 04/04/2002 | US20020039749 Analyzing using phosphated tyrosine compound |
| 04/04/2002 | US20020039745 Anti-inflammatory compositions and method |
| 04/04/2002 | CA2420045A1 Melanocortin receptor ligands |
| 04/03/2002 | EP1192177A1 Statine-derived tetrapeptide inhibitors of beta-secretase |
| 04/03/2002 | EP1192119A2 Process for the preparation of 3,3-dimethylbutanal |
| 04/03/2002 | EP1191939A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
| 04/03/2002 | EP1191932A1 Production of agglomerates of inogatran and the compound inogatran anhydrate |
| 04/03/2002 | EP0934075B1 Micrococcin atibiotic for the prevention and treatment of mastitis |
| 04/03/2002 | CN1343220A Method for producing cyclo-(Asp-Dphe-NMeval-Arg-Gly) |
| 04/03/2002 | CN1343219A Substituted phenethylamine derivatives |
| 04/03/2002 | CN1343218A Method for preparing bicyclic compounds and use of said method for preparing inhibitor compound |
| 04/03/2002 | CN1343217A New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 04/03/2002 | CN1343205A Dimeric compounds and as inhibitors of neuraminidase |
| 04/02/2002 | US6365592 For therapy of diabetes, glucose intolerance, insulin resistance, and obesity |
| 04/02/2002 | US6365572 For therapy of diseases related to increased or unwanted synthesis of basement membranes such as diabetes mellitus; atherosclerosis; cancer; diabetic retinopathia; fibroplasia retrolentalis; or psoriasis, rheumatoic arthritis |
| 04/02/2002 | US6365217 N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester agglomerate |
| 04/02/2002 | CA2053340C Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 03/28/2002 | WO2002024725A1 Selective growth media |
| 03/28/2002 | WO2002024218A1 Angiogenic agents and their uses |
| 03/28/2002 | US20020038046 Washing N-(N-(3,3-dimethylbutyl)-L-alpha aspartyl)-L-phenylalanine 1-methyl ester with water; combining with organic solvent to from slurry, filtering to recover purified compound |
| 03/28/2002 | US20020037998 For therapy of hepatitis C virus (HCV) infection |
| 03/28/2002 | US20020037997 Beta-amino acids |